[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Mumps Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

October 2019 | 40 pages | ID: M519D4BF498DEN
VPAResearch

US$ 1,699.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Mumps Drug pipeline report- 2020 is an annual R&D review of Mumps pipeline candidates. The report presents the current status of all major Mumps therapeutic compounds. Detailed insights into Mumps pipeline development, current status, companies, drug profiles and Mumps preclinical and clinical trials are included.

2020 Mumps Pipeline Market Insights
Mumps disease overview, 2020 pipeline review, insights into leading companies, dominant mechanism of action, majority of administration route of Mumps therapies, pipeline by phase and others are included.

Mumps pipeline Drug profiles-
Active and inactive drug profiles covering information including drug name/synonym, sponsor/collaborators/Developer/originator, drug mechanism, route of administration, orphan drug status, NME, phase, development status, and others are included.

Mumps Therapeutic Drug candidates
Both active and inactive Mumps pipeline drug candidates are included in the report

Mumps Clinical Trials and preclinical Studies
Mumps In-vitro and In-vivo studies, discovery stage and pre-clinical stage trial details, Clinical trial titles, duration, location, phase, sponsors, and other details are provided.

Mumps pipeline market developments
Mumps Pipeline market news and deals including mergers, acquisitions, approvals, collaborations, trial initiations, results, investments, licensing opportunities and others are provided.

Mumps pipeline companies in active development
The report analyzes Mumps pipeline of the below companies-

Cadila Healthcare Limited , Daiichi Sankyo Co Ltd , GlaxoSmithKline Plc, Sinovac Biotech Ltd

Report Coverage

What to look out for in 2020
Drugs moving from early stage to mid-to-late stages and drugs to look after in 2020 are included

Pipeline Snapshot
Pipeline candidate count - Drug by phase, mechanism of action, route of administration, designation and others

Companies
4 Companies investing in Mumps pipeline from discovery stage to pre-registration phase are included

Drug profiles
Over 10 details of each Mumps pipeline candidate are included

Company Profiles
Business overview and contact details of all companies operating in the industry are provided

Market Developments
News, Developments and other recent industry developments are included
1. MUMPS PIPELINE MARKET INSIGHTS, 2020

1.1 Mumps Disease Overview
1.2 Mumps Drug Pipeline Snapshot, 2020
  1.2.1 Mumps Pipeline Drugs by Phase
  1.2.2 Mumps Pipeline Drugs by Company
  1.2.3 Mumps Pipeline Drugs by Mechanism of Action
  1.2.4 Mumps Pipeline Drugs by Route of Administration

2. MUMPS COMPANY WISE PIPELINE DETAILS

Cadila Healthcare Limited Mumps Pipeline Drugs
  Company Profile
  Drug Candidate Details
Daiichi Sankyo Co Ltd Mumps Pipeline Drugs
  Company Profile
  Drug Candidate Details
GlaxoSmithKline Plc Mumps Pipeline Drugs
  Company Profile
  Drug Candidate Details
Sinovac Biotech Ltd Mumps Pipeline Drugs
  Company Profile
  Drug Candidate Details

3. MUMPS DRUG PIPELINE PROFILES

3.1 Discovery and Preclinical Drug Profiles
3.2 Phase 1 Drug Profiles
3.3 Phase 2 Drug Profiles
3.4 Phase 3 Drug Profiles

4. MUMPS PIPELINE NEWS AND DEVELOPMENTS

5. APPENDIX

5.1 Primary and Secondary Research Methodology
5.2 Publisher Expertize
5.3 Contacts


More Publications